Recent

% | $
Quotes you view appear here for quick access.

Geron Corporation Message Board

  • lws2000 lws2000 Apr 16, 2013 3:49 PM Flag

    The "Great White Hope"

    MENLO PARK, Calif., April 9, 2013 - Geron Corporation (Nasdaq: GERN) today announced presentation of the final results from the Phase 2 study of imetelstat, the company's first-in-class telomerase inhibitor, as maintenance therapy following platinum-based induction chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) at the American Association for Cancer Research (AACR) 2013 Annual Meeting, currently taking place in Washington, D.C.

 
GERN
2.67+0.03(+1.14%)11:44 AMEST